R&D
![COVID and influenza vaccines](https://pharmaphorum.com/wp-content/uploads/2022/09/COVID-and-influenza-vaccines.jpg)
Reconfiguring COVID and influenza vaccines for long-term eff...
Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company's breakthrough vaccine technology, oligoDOM, and how it's driving the development of new influenza and SARS-CoV-2 vacc